Literature DB >> 19219553

From genotype to phenotype: a longitudinal study of a patient with hypertrophic cardiomyopathy due to a mutation in the MYBPC3 gene.

Adam Jacques1, Anita C Hoskins, Jonathan C Kentish, Steven B Marston.   

Abstract

Many of the links between the genotype and phenotype in hypertrophic cardiomyopathy remain unexplained. In this unique longitudinal study we have investigated a patient with classical clinical phenotypic features of hypertrophic obstructive cardiomyopathy, with a known mutation in MYBPC3, the most commonly affected gene in this disease. By collecting cardiac tissue from the patient at the time of surgical myectomy for relief of left ventricular outflow tract obstruction, we have been able to examine the structure of the myocytes and the functional differences that occur in MyBP-C mutated HCM cardiac tissue from single protein level, onto single cardiomyocyte contractility, through to whole organ function as assessed clinically by echocardiography.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219553     DOI: 10.1007/s10974-009-9174-0

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  23 in total

1.  Mutation of the myosin converter domain alters cross-bridge elasticity.

Authors:  Jan Köhler; Gerhard Winkler; Imke Schulte; Tim Scholz; William McKenna; Bernhard Brenner; Theresia Kraft
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Perry M Elliott; Juan R Gimeno; María T Tomé; Jaymin Shah; Deirdre Ward; Rajesh Thaman; Jens Mogensen; William J McKenna
Journal:  Eur Heart J       Date:  2006-06-05       Impact factor: 29.983

3.  Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.

Authors:  B C Knollmann; J D Potter
Journal:  Trends Cardiovasc Med       Date:  2001-07       Impact factor: 6.677

4.  Hypertrophic cardiomyopathy-related beta-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells.

Authors:  Sebastian E Kirschner; Edgar Becker; Massimo Antognozzi; Hans-Peter Kubis; Antonio Francino; Francisco Navarro-López; Nana Bit-Avragim; Andreas Perrot; Mirsaid M Mirrakhimov; Karl-Josef Osterziel; William J McKenna; Bernhard Brenner; Theresia Kraft
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11-18       Impact factor: 4.733

5.  Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.

Authors:  Sara L Van Driest; Vlad C Vasile; Steve R Ommen; Melissa L Will; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

6.  Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.

Authors:  S Firoozi; P M Elliott; S Sharma; A Murday; S J Brecker; M S Hamid; B Sachdev; R Thaman; W J McKenna
Journal:  Eur Heart J       Date:  2002-10       Impact factor: 29.983

7.  Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle.

Authors:  Adam M Jacques; O'Neal Copeland; Andrew E Messer; Clare E Gallon; Katie King; William J McKenna; Victor T Tsang; Steven B Marston
Journal:  J Mol Cell Cardiol       Date:  2008-06-04       Impact factor: 5.000

8.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.

Authors:  J van der Velden; Z Papp; R Zaremba; N M Boontje; J W de Jong; V J Owen; P B J Burton; P Goldmann; K Jaquet; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

9.  Alterations in Ca2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers.

Authors:  P A Hofmann; H C Hartzell; R L Moss
Journal:  J Gen Physiol       Date:  1991-06       Impact factor: 4.086

10.  The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy.

Authors:  Adam M Jacques; Natalia Briceno; Andrew E Messer; Clare E Gallon; Shapour Jalilzadeh; Edwin Garcia; Gaelle Kikonda-Kanda; Jennifer Goddard; Sian E Harding; Hugh Watkins; M Tomé Esteban; Victor T Tsang; William J McKenna; Steven B Marston
Journal:  Cardiovasc Res       Date:  2008-04-14       Impact factor: 10.787

View more
  20 in total

Review 1.  Mechanical and energetic consequences of HCM-causing mutations.

Authors:  Cecilia Ferrantini; Alexandra Belus; Nicoletta Piroddi; Beatrice Scellini; Chiara Tesi; Corrado Poggesi
Journal:  J Cardiovasc Transl Res       Date:  2009-10-09       Impact factor: 4.132

2.  Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.

Authors:  Weihua Song; Emma Dyer; Daniel J Stuckey; O'Neal Copeland; Man-Ching Leung; Christopher Bayliss; Andrew Messer; Ross Wilkinson; Jordi Lopez Tremoleda; Michael D Schneider; Sian E Harding; Charles S Redwood; Kieran Clarke; Kristen Nowak; Lorenzo Monserrat; Dominic Wells; Steven B Marston
Journal:  J Biol Chem       Date:  2011-05-26       Impact factor: 5.157

3.  Cardiac myosin binding protein C insufficiency leads to early onset of mechanical dysfunction.

Authors:  Candida L Desjardins; Yong Chen; Arthur T Coulton; Brian D Hoit; Xin Yu; Julian E Stelzer
Journal:  Circ Cardiovasc Imaging       Date:  2011-12-07       Impact factor: 7.792

4.  HSC70 is a chaperone for wild-type and mutant cardiac myosin binding protein C.

Authors:  Amelia A Glazier; Neha Hafeez; Dattatreya Mellacheruvu; Venkatesha Basrur; Alexey I Nesvizhskii; Lap Man Lee; Hao Shao; Vi Tang; Jaime M Yob; Jason E Gestwicki; Adam S Helms; Sharlene M Day
Journal:  JCI Insight       Date:  2018-06-07

5.  Manganese-enhanced MRI detection of impaired calcium regulation in a mouse model of cardiac hypertrophy.

Authors:  Martin Andrews; Maryellen L Giger; Brian B Roman
Journal:  NMR Biomed       Date:  2014-12-19       Impact factor: 4.044

Review 6.  How do mutations in contractile proteins cause the primary familial cardiomyopathies?

Authors:  Steven B Marston
Journal:  J Cardiovasc Transl Res       Date:  2011-03-22       Impact factor: 4.132

Review 7.  Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy.

Authors:  Amelia A Glazier; Andrea Thompson; Sharlene M Day
Journal:  Pflugers Arch       Date:  2018-11-20       Impact factor: 3.657

8.  Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.

Authors:  Aref Najafi; Saskia Schlossarek; Elza D van Deel; Nikki van den Heuvel; Ahmet Güçlü; Max Goebel; Diederik W D Kuster; Lucie Carrier; Jolanda van der Velden
Journal:  Pflugers Arch       Date:  2014-07-11       Impact factor: 3.657

9.  Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere.

Authors:  Y Cheng; X Wan; T A McElfresh; X Chen; K S Gresham; D S Rosenbaum; M P Chandler; J E Stelzer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-10       Impact factor: 4.733

Review 10.  Genetic, clinical, molecular, and pathogenic aspects of the South Asian-specific polymorphic MYBPC3Δ25bp variant.

Authors:  Mohammed Arif; Pooneh Nabavizadeh; Taejeong Song; Darshini Desai; Rohit Singh; Sholeh Bazrafshan; Mohit Kumar; Yigang Wang; Richard J Gilbert; Perundurai S Dhandapany; Richard C Becker; Evangelia G Kranias; Sakthivel Sadayappan
Journal:  Biophys Rev       Date:  2020-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.